Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Meeting Highlights
GU Cancers Symposium Highlights
,
Renal-Cell Carcinoma
Sitravatinib, Novel TKI, plus Nivolumab Elicits Good Responses in Renal-Cell Carcinoma
Read More
Meeting Highlights
GU Cancers Symposium Highlights
,
Renal-Cell Carcinoma
First-in-Class Oral MK-6482 Shows Exciting Results in Clear-Cell Renal-Cell Carcinoma
Read More
Online Only
COVID-19
Wholesale Supply Channels Addressing the Pandemic
Tommy Pourmahram
,
Barry Fortner, PhD
Read More
Online Only
COVID-19
Revenue Cycle Management in Oncology
Brian Gockerman, MBA
,
Parag Shah
Read More
Online Only
COVID-19
Managed Care Payers During the Pandemic
Steven Peskin, MD, MBA, FACP
,
Scott Breidbart, MD, MBA
,
Matthew Eyles
Read More
COVID-19
Washington and Public Policy: The COVID-19 Pandemic
Scott Gottlieb, MD
Read More
COVID-19
Comprehensive Cancer Care Systems
Robert Carlson, MD
,
Pat Basu, MD, MBA
,
Christian Downs, MHA, JD
Read More
Online Only
COVID-19
Community Care Providers and COVID-19
Read More
COVID-19
Pharmaceutical Manufacturers’ Response to COVID-19
Julie Gerberding, MD
,
Brian Morrissey
,
Eric Dozier
Read More
COVID-19
Oncology Pharmacy Making Adjustments
Michael Reff, RPh, MBA
,
Ray Bailey, BPharm, RPh
Read More
134
135
136
137
138
139
140
Page 137 of 196
Results 1361 - 1370 of 1954
